Invests at
Angel
does not invest at this round
Pre-seed
does not invest at this round
Seed
invests at this round
Series A
invests at this round
Series B
invests at this round
Check size
- $10M to $30M
- Over $30M
Ownership target
7% to 10%
Latest fund
$1.3B (Fund III)Vintage 2025
Lead or follow
Can Lead
Focus
Specialist
About
TCGX is a science-driven investment firm focused on innovative biotechnology companies developing transformative medicines. Its closed-end fund structure supports private and public companies across the drug-development lifecycle.
Sectors
Investors
How to reach them
info@tcgcrossover.com
Sources
Record from findfunding.vc